Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JVU
|
|||
| Former ID |
DIB013640
|
|||
| Drug Name |
Long-acting IFN-alpha
|
|||
| Synonyms |
HM-10660; HM-10660A; LAPS-IFN-alpha; LAPS-INF-alpha; Long-acting IFN-alpha (LAPS, cancer/HCV); Long-acting IFN-alpha (LAPS, cancer/HCV), Hanmi
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1/2 | [1] | |
| Company |
Hanmi Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02057887) Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.